This document discusses recent advances in malaria treatment and new antimalarial drugs. It provides background on malaria as a protozoan disease transmitted by mosquitoes that places a heavy burden on tropical countries. Six Plasmodium species cause nearly all human malaria infections. The life cycle and pathophysiology of malaria parasites are described. The document reviews the clinical features, diagnosis, drug resistance, antimalarial drug targets, and treatment guidelines for both uncomplicated and resistant forms of malaria caused by different Plasmodium species.
1 of 84
Downloaded 55 times
More Related Content
Malaria, recent advances and new anti malarials
1. MALARIA ,RECENT ADVANCE AND
NEW ANTI MALARIAL DRUGS
DR MUKESH KUMAR SAMOTA
MD(INTERNAL MEDICINE)
GOVT. MEDICAL COLLEGE AND HOSPITAL, JHALAWAR
RAJASTHAN (INDIA).
2. INTODUCTION
M A L A R I A I S A P R O TO Z O A N D I S E A S E
T R A N S M I T T E D B Y F E M A L E A N A P H E L E S
M O S Q U I TO E S
H E AV Y B U R D E N I N T R O P I C A L C O U N T R I E S
M O S T I M P O RTA N T PA R A S I T I C D I S E A S E
O F H U M A N T R A N S M I T T E D I N 3 B I L L I O N
P E O P L E W O R D W I D E A N D A P P R O X 2 0 0 0
D E AT H / D AY W O R D W I D E .
6 S P E C I E S O F G E N U S P L A S M O D I U N
C A U S E N E A R LY A L L M A L A R I A
I N F E C T I O N S I N H U M A N S
6. PATHOPHYSIOLOGY
After invading RBC growing parasites consume intracellular proteins principally
Hb and
Potentially toxic heme is converted to biologically inert hemozoin (malaria
pigment).
Parasites alters RBC membrane by changing its transport property and
expososing cryptic surface antigens.
In erythrocytic cycle RBC ruptures and release malarial pigments and other
proteins which stimulate host immune system
Stimulation of macrophages and cells occur which release proinflammatory
mediators and it cause clinical features .
In case of Pf there is cyto adherence, agglutination, rosette formation of infected
RBC leads to occludes capillaries and vessels which is responsible for sever
and complicated malaria
36. OTHERS
MEFLOQUINE
250 mg weekly for adults
used in area of chq resist Pf
DOXYCUCLINE
100 mg daily start 2 days before to 4week after
C/I For pregnancy and chldren <8 yrs of age
PRIMAQUINE
0.5mg/kg daily
38. TREATMENT OF MALARIA
UNCOMPLICATED MALARIA
(A) CHQ SENSITIVE PL. VIVAX
1.CHQ 10 mg/kg PO stat then5mg/kg@12h
then 5mg/kg @24 and 36 h
OR
10 mg/kg BW stat then 10 mg/kg BW @24 hrs and
5mg/kg BW48 hrs
PLUS
Primaquin 0.25mg/kg for 14 days
39. (B)CHQ RESISTENT PL. VIVAX
1.QUININE 600MG(10MG/DAY) 8H FOR7DAY
PLUS
DOXYCYCLINE100MG DAILY FOR 7 DAYS PLUS
PRIMAQUINE15MG FOR 14 DAYS
2. ACT PLUS PRIMAQUINE